Shacham Sharon
- SEC CIK
- 0001588438
No open-market purchases or sales filed in the past year.
Current role at each company
- ACRV Acrivon Therapeutics, Inc.Directoras of Jun 22, 2026
- KPTI Karyopharm Therapeutics Inc.Chief Scientific Officeras of Mar 31, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Shacham Sharon as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KPTI Karyopharm Therapeutics Inc.
Chief Scientific Officer6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2022 (view filing) | Feb 28 | 2 days | Shacham SharonChief Scientific Officer | SSale | −6.23K | $10.24 | −$63.8K | −0.7%898.1K after | Duplicate filing |
| Mar 2, 2022 (view filing) | Feb 28 | 2 days | Shacham SharonChief Scientific Officer | SSale | −6.23K | $10.24 | −$63.8K | −0.9%713.8K after | Duplicate filing |
| Feb 22, 2022 (view filing) | Feb 17 | 5 days | Shacham SharonChief Scientific Officer | SSale | −9.09K | $12.12 | −$110.1K | −1.0%904.4K after | Duplicate filing |
| Feb 22, 2022 (view filing) | Feb 17 | 5 days | Shacham SharonChief Scientific Officer | SSale | −9.08K | $12.12 | −$110.0K | −1.3%699.0K after | Duplicate filing |
| Feb 9, 2022 (view filing) | Feb 7 | 2 days | Shacham SharonChief Scientific Officer | SSale | −6.71K | $9.86 | −$66.1K | −0.7%913.4K after | |
| Feb 9, 2022 (view filing) | Feb 7 | 2 days | Shacham SharonChief Scientific Officer | SSale | −6.76K | $9.86 | −$66.7K | −0.9%708.1K after |